Slide background
Slide background




Guidance on identifying endocrine disruptors

ID 6291 | | Visite: 2536 | Documenti Chemicals ECHAPermalink: https://www.certifico.com/id/6291

Guidance on identifying endocrine disruptors

Guidance on identifying endocrine disruptors 

ECHA/NR/18/36

Scientific criteria have been agreed to identify endocrine disruptors under the EU legislation for pesticides and biocides. The criteria for biocides apply from 7 June 2018.

Pre-publication version of the Guidance for Identification of Endocrine Disruptors in the Context of the Biocidal Products and Plant Protection Products Regulations available

This Guidance was developed jointly by ECHA and the European Food Safety Authority (EFSA) with support by the Joint Research Centre (JRC) and describes how to identify endocrine disruptors in the context of the Biocidal Products Regulation (EU) No 528/2012 and the Plant Protection Products Regulation (EC) No 1107/2009 in accordance with the scientific criteria for the determination of endocrine disrupting properties set out in Commission Delegated Regulation (EU) 2017/2100 and Commission Regulation (EU) 2018/605. The final guidance will be published in the EFSA Journal by July 2018. 

Helsinki, 7 June 2018

A drafting group consisting of scientific staff from ECHA and the European Food Safety Authority (EFSA), with the support of the Joint Research Centre (JRC), have developed scientific guidance to enable the identification of endocrine disruptors. The guidance advises applicants and assessors of the competent regulatory authorities on how to identify endocrine disruptors in accordance with the endocrine disruptor criteria.

The European Commission tasked ECHA and EFSA to develop the guidance to ensure harmonised implementation of the endocrine disruptor criteria throughout the EU for the assessment of biocides and plant protection products. The guidance has been consulted with the Agencies’ stakeholders, ECHA’s endocrine disruptor expert group and Member States’ biocides and pesticides competent authorities.

The European Commission (EC) asked the European Food Safety Authority (EFSA) and the European Chemicals Agency (ECHA) to develop a guidance document for the implementation of the scientific criteria for the determination of endocrine-disrupting properties pursuant to the Biocidal Products Regulation (EU) No 528/2012 and the Plant Protection Products Regulation (EC) No 1107/2009.

This guidance document is written to provide guidance to applicants and assessors of competent regulatory authorities on how to identify endocrine disruptors in accordance with the ED criteria laid down in Commission Delegated Regulation (EU) No 2017/2100 and Commission Regulation (EU) No 2018/605 for biocidal products (BP) and plant protection products (PPP), respectively. The guidance document describes how to gather, evaluate and consider all relevant information for the assessment,
conduct a mode of action (MoA) analysis, and apply a weight of evidence (WoE) approach, in order to establish whether the ED criteria are fulfilled.

The guidance document has been subject to several consultations which are summarised in a technical report (ECHA and EFSA, 2018) . It was consulted twice with an ad-hoc Consultation Group of Member States experts and stakeholders (April-May 2017 and July-August 2017). A general public consultation was held (December 2017-January 2018) to which any interested party could respond. A targeted consultation of risk assessors from competent authorities in the plant protection and biocidal product sectors were consulted in parallel with the EFSA Scientific Committee and the EFSA Panel on plant protection products and their residues (April 2018). Finally, risk managers of the competent authorities for biocidal products and of those for plant protection products were consulted, before adoption of the guidance by ECHA and EFSA according to their procedure (May 2018). When revising the guidance following the above consultations, the overall feedback received and the status of scientific knowledge was considered and it was acknowledged that the document, in future, may need to be revised, when relevant further scientific knowledge becomes available and on the basis of the experience acquired with the application of the present guidance document.

Chapter 3 presents the assessment strategy for determining whether a substance meets the ED criteria.
The strategy is based on the requirements outlined in the ED criteria. An approach is proposed for analysing the information provided in a dossier submitted for approval of a substance in the context of the PPP or BP Regulations.

Chapter 4 gives an overview on the information sources that may provide suitable information for ED identification and therefore should be considered for the assessment. In addition, Chapter 4 provides guidance on how to consider the scientific data generated in accordance with internationally agreed study protocols in order to facilitate the evaluation of both adverse effects and endocrine activity (by following the process explained in Chapter 3). The rationale for grouping effects is based on the ‘Guidance Document on standardised test guidelines for evaluating chemicals for endocrine disruption.

Series on Testing and Assessment No. 150’ provided by the Organisation for Economic Co-operation and Development (OECD) (OECD, 2018b) for their interpretation with regard to estrogenic, androgenic, thyroidal and steroidogenic (EATS) modalities and adapting the Joint Research Centre’s (JRC) screening methodology to identify potential endocrine disruptors (JRC, 2016).

Chapter 5 gives recommendations for applicants and assessors from evaluating authorities and for future research and Chapter 6 provides the references. The guidance is complemented with a list of abbreviations and a glossary of terms and definitions used in the text, and several appendices providing information on some specific scientific or technical issues (Appendix A – Additional considerations on how to assess the potential for thyroid disruption; Appendix B – Recommendations for design, conduct and technical evaluation of hormonal studies; Appendix C – Information requirements under the BP and PPP Regulations; Appendix D – Databases, software tools and literature-derived (Q)SARs; Appendix E – Excel template for reporting the available information relevant for ED assessment; Appendix F – Example on how to develop the search strategy protocol; and Appendix G – Example of MoA for nontarget organisms (fish)).

___________

LEGAL NOTICE
ABBREVIATIONS
GLOSSARY OF TERMS
1. INTRODUCTION
2. SCOPE OF THE GUIDANCE DOCUMENT
3. STRATEGY TO ASSESS WHETHER A SUBSTANCE MEETS THE ENDOCRINE DISRUPTOR CRITERIA
3.1. General overview of the assessment strategy
3.1.1. Grouping of parameters relevant for identification of endocrine disrupting properties
3.1.2. Considerations on non-EATS modalities
3.1.3. The assessment strategy
3.2. Gather all relevant information
3.2.1. Evaluate relevance and reliability of the data
3.2.1.1. Data from standard studies
3.2.1.2. Other scientific data
3.2.2. Extracting and reporting the information
3.3. Assemble and assess lines of evidence for endocrine activity and adversity
3.3.1. Assembling and assessing the line(s) of evidence for adverse effects
3.3.1.1. Effects secondary to other toxicities
3.3.1.2. Low-dose effects and non-monotonic dose response (NMDR)
3.3.1.3. Human relevance
3.3.1.4. Population relevance
3.3.2. Assembling and assessing the line(s) of evidence for endocrine activity
3.3.3. Integration of the lines of evidence for adverse effects and endocrine activity
3.3.4. Reporting the lines of evidence
3.4. Initial analysis of the evidence
3.4.1. Sufficient dataset for EATS-mediated adversity to support a conclusion on absence of EATS mediated adversity
3.4.2. Sufficient dataset for EATS-related endocrine activity to support a conclusion on absence of EATS-related endocrine activity
3.4.3. Considerations on the generation of further data
3.4.4. Scenarios
3.4.4.1. Scenarios based on ‘EATS-mediated’ parameters sufficiently investigated
3.4.4.2. Scenarios based on ‘EATS-mediated’ parameters not sufficiently investigated
3.5. Mode of Action (MoA) analysis
3.5.1. Postulate MoA(s) considering the adversity and/or endocrine activity
3.5.2. Establish the biologically plausible link
3.5.3. Consider which further information could help to clarify the postulated MoA(s)
3.5.4. Additional considerations for non-endocrine or non-EATS mediated MoA(s)
3.5.4.1. Biological plausibility for the key event relationships
3.5.4.2. Empirical support for dose–response/incidence and temporal concordance for the key event relationship
3.5.4.3. Essentiality, consistency, analogy and specificity of the evidence for the association of the KEs with the adverse effect
3.5.4.4. Human relevance
3.5.5. Extent of support for the overall assessment of the MoA analysis
3.5.6. Conclusion on the MoA analysis
3.6. Overall conclusion on the ED criteria
4. INFORMATION SOURCES FOR ENDOCRINE DISRUPTOR IDENTIFICATION
4.1. Non-test methods
4.2. In vitro test methods
4.3. In vivo test methods
4.3.1. Mammalian
4.3.1.1. OECD CF level 3 tests
4.3.1.2. OECD CF level 4 and 5 tests
4.3.2. Non-mammalian
4.3.2.1. Parameters
4.3.2.2. Fish
4.3.2.3. Amphibians
4.3.2.4. Birds
4.4. Epidemiological data, field studies and population models
4.4.1. Epidemiological data
4.4.2. Field studies and monitoring data
4.4.3. Population models
5. RECOMMENDATIONS
5.1. Recommendations for applicants and assessors
5.2. Recommendations for future research
6. REFERENCES
APPENDIX A – ADDITIONAL CONSIDERATIONS ON HOW TO ASSESS THE POTENTIAL FOR THYROID DISRUPTION FOR HUMAN HEALTH
APPENDIX B – RECOMMENDATIONS FOR DESIGN, CONDUCTION AND TECHNICAL EVALUATION OF HORMONAL STUDIES
APPENDIX C – INFORMATION REQUIREMENTS FOR ACTIVE SUBSTANCES UNDER THE BIOCIDAL PRODUCTS AND PLANT PROTECTION PRODUCTS
REGULATIONS, WHICH COULD POTENTIALLY PROVIDE INFORMATION ON ENDOCRINE-DISRUPTING PROPERTIES
APPENDIX D – DATABASES, SOFTWARE TOOLS AND LITERATURE-DERIVED (Q)SARS
APPENDIX E – EXCEL TEMPLATE FOR REPORTING THE AVAILABLE INFORMATION RELEVANT FOR ED ASSESSMENT
APPENDIX F – EXAMPLE ON HOW TO DEVELOP THE SEARCH STRATEGY PROTOCOL
APPENDIX G – EXAMPLE OF MOA FOR NON-TARGET ORGANISMS (FISH)

Fonte: ECHA

Collegati:



Tags: Chemicals Regolamento BPR Abbonati Chemicals Guida ECHA

Articoli correlati

Ultimi archiviati Chemicals

Decreto 16 Aprile 2021
Mag 05, 2021 9

Decreto 16 aprile 2021 | Suppl. 10.4 Farmacopea Europea 10ª Ed.

Decreto 16 aprile 2021 Entrata in vigore dei testi, nelle lingue inglese e francese, pubblicati nel Supplemento 10.4 della Farmacopea europea 10ª edizione. (GU n.106 del 05.05.2021) ...[box-info]Aggiornamenti10.0 Decreto 9 febbraio 2020 | 10ª edizione della Farmacopea Europea10.1 Decreto 2 aprile… Leggi tutto
Decisione UE 2021 727
Mag 05, 2021 11

Decisione (UE) 2021/727

Decisione (UE) 2021/727 del Consiglio del 29 aprile 2021 relativa alla presentazione, a nome dell’Unione europea, di proposte di modifica degli allegati A e B della convenzione di Minamata sul mercurio riguardanti i prodotti con aggiunta di mercurio e i processi di fabbricazione che comportano… Leggi tutto
Mag 04, 2021 13

Regolamento (UE) n. 518/2013

Regolamento (UE) n. 518/2013 Regolamento (UE) n. 518/2013 del Consiglio, del 13 maggio 2013, che adatta il regolamento (CE) n. 1107/2009 del Parlamento europeo e del Consiglio in ragione dell'adesione della Repubblica di Croazia (GU L 158 del 10.6.2013) Collegati[box-note]Regolamento (CE)… Leggi tutto
Mag 04, 2021 12

Regolamento (UE) 2018/605

Regolamento (UE) 2018/605 Regolamento (UE) 2018/605 della Commissione, del 19 aprile 2018, che modifica l'allegato II del regolamento (CE) n. 1107/2009 stabilendo criteri scientifici per la determinazione delle proprietà di interferente endocrino. (GU L 101 del 20.4.2018)… Leggi tutto
Mag 04, 2021 31

Regolamento (UE) 2015/2283

Regolamento (UE) 2015/2283 Regolamento (UE) 2015/2283 del Parlamento europeo e del Consiglio, del 25 novembre 2015, relativo ai nuovi alimenti e che modifica il regolamento (UE) n. 1169/2011 del Parlamento europeo e del Consiglio e abroga il regolamento (CE) n. 258/97 del Parlamento europeo e del… Leggi tutto
Mag 04, 2021 39

Regolamento (CE) n. 1331/2008

Regolamento (CE) n. 1331/2008 Regolamento (CE) n. 1331/2008 del Parlamento europeo e del Consiglio, del 16 dicembre 2008, che istituisce una procedura uniforme di autorizzazione per gli additivi, gli enzimi e gli aromi alimentari. (GU L 354 del 31.12.2008) In allegato: - Testo nativo- Testo… Leggi tutto
Mag 03, 2021 22

Regolamento (UE) 1282/2011

Regolamento (UE) 1282/2011 Regolamento (UE) n. 1282/2011 della Commissione del 28 novembre 2011 che modifica e corregge il regolamento (UE) n. 10/2011 della Commissione riguardante i materiali e gli oggetti di materia plastica destinati a venire a contatto con i prodotti alimentari. (GU L 328 del… Leggi tutto
Mag 03, 2021 23

Regolamento (UE) 1183/2012

Regolamento (UE) 1183/2012 Regolamento (UE) n. 1183/2012 della Commissione del 30 novembre 2012 che modifica e corregge il regolamento (UE) n. 10/2011 riguardante i materiali e gli oggetti di materia plastica destinati a venire a contatto con i prodotti alimentari. (GU L 338 del 12.12.2012)… Leggi tutto
Mag 03, 2021 24

Regolamento (UE) 865/2014

Regolamento (UE) 865/2014 Regolamento (UE) n. 865/2014 della Commissione dell'8 agosto 2014 che corregge la versione spagnola del regolamento (UE) n. 10/2011 riguardante i materiali e gli oggetti di materia plastica destinati a venire a contatto con i prodotti alimentari. (GU L 238 del 9.8.2014)… Leggi tutto
Mag 03, 2021 23

Regolamento di esecuzione (UE) 321/2011

Regolamento di esecuzione (UE) 321/2011 Regolamento di esecuzione (UE) n. 321/2011 della Commissione del 1 aprile 2011 che modifica il regolamento (UE) n. 10/2011 per quanto riguarda le restrizioni d'uso del bisfenolo A nei biberon di plastica. (GU L 87 del 2.4.2011) Collegati[box-note]Regolamento… Leggi tutto

Più letti Chemicals

Regolamento  CE  n  178 2002
Mag 04, 2021 44374

Regolamento (CE) N. 178/2002

Regolamento (CE) n. 178/2002 Regolamento (CE) n. 178/2002 del Parlamento europeo e del Consiglio del 28 gennaio 2002 che stabilisce i principi e i requisiti generali della legislazione alimentare, istituisce l'Autorità europea per la sicurezza alimentare e fissa procedure nel campo della sicurezza… Leggi tutto